TRAD CHI MED (00570) Income Statement & Earnings

1.690
-0.010-0.59%

Market Closed Apr 30 15:54 CST

8.51BMarket Cap-22.53P/E (TTM)

TRAD CHI MED (00570) Income Statement

All

YOY

Hide blank lines

(FY)Dec 31, 2025

(Q6)Jun 30, 2025

(FY)Dec 31, 2024

(Q6)Jun 30, 2024

(FY)Dec 31, 2023

(Q6)Jun 30, 2023

(FY)Dec 31, 2022

(Q6)Jun 30, 2022

(FY)Dec 31, 2021

(Q6)Jun 30, 2021

Turnover

-10.69%14.74B

-11.00%7.46B

-8.90%16.51B

-9.86%8.39B

26.69%18.12B

57.37%9.3B

-24.92%14.3B

-27.46%5.91B

28.68%19.05B

22.45%8.15B

Operating income

-10.69%14.74B

-11.00%7.46B

-8.90%16.51B

-9.86%8.39B

26.69%18.12B

57.37%9.3B

-24.92%14.3B

-27.46%5.91B

28.68%19.05B

22.45%8.15B

Cost of sales

11.55%-7.65B

11.46%-3.83B

2.19%-8.65B

4.86%-4.32B

-24.51%-8.85B

-53.56%-4.54B

1.63%-7.11B

5.94%-2.96B

-27.17%-7.22B

-19.26%-3.15B

Operating expenses

11.55%-7.65B

11.46%-3.83B

2.19%-8.65B

4.86%-4.32B

-24.51%-8.85B

-53.56%-4.54B

1.63%-7.11B

5.94%-2.96B

-27.17%-7.22B

-19.26%-3.15B

Gross profit

-9.74%7.09B

-10.51%3.63B

-15.29%7.86B

-14.64%4.06B

28.84%9.27B

61.19%4.76B

-39.15%7.2B

-41.00%2.95B

29.62%11.83B

24.54%5B

Selling expenses

8.57%-4.95B

7.13%-2.56B

15.37%-5.42B

13.63%-2.75B

-39.08%-6.4B

-85.61%-3.19B

39.28%-4.6B

43.58%-1.72B

-35.71%-7.58B

-24.58%-3.04B

Administrative expenses

-5.46%-1.12B

2.27%-500.54M

-1.38%-1.06B

-10.20%-512.15M

-10.47%-1.04B

-15.72%-464.75M

3.08%-944.4M

-5.77%-401.61M

-37.77%-974.45M

-13.79%-379.7M

Research and development expenses

14.18%-511.47M

4.40%-256.12M

13.07%-596.01M

14.57%-267.93M

-12.06%-685.63M

1.23%-313.61M

11.90%-611.83M

-7.75%-317.53M

-26.15%-694.44M

-20.13%-294.7M

Impairment and provision

-99.49%-212.57M

-17.07%-185.88M

-1,037.67%-106.55M

-232.37%-158.77M

7.02%-9.37M

-29.33%-47.77M

27.42%-10.07M

20.19%-36.94M

74.17%-13.88M

-39.65%-46.28M

-Other impairment is provision

-99.49%-212.57M

-17.07%-185.88M

-1,037.67%-106.55M

-232.37%-158.77M

7.02%-9.37M

-29.33%-47.77M

27.42%-10.07M

20.19%-36.94M

74.17%-13.88M

-39.65%-46.28M

Special items of operating profit

-65.79%-565.7M

-1,255.45%-171.34M

-215.94%-341.22M

-78.55%14.83M

712.16%294.3M

-24.19%69.13M

-80.79%36.24M

18.56%91.19M

-28.22%188.63M

-47.42%76.91M

Operating profit

-180.13%-268.9M

-109.28%-35.69M

-76.49%335.59M

-52.76%384.58M

34.11%1.43B

42.82%814.05M

-61.34%1.06B

-56.68%569.97M

10.54%2.75B

18.73%1.32B

Financing cost

42.21%-99.13M

43.99%-47.2M

13.82%-171.54M

20.07%-84.27M

9.81%-199.05M

-6.97%-105.44M

0.60%-220.7M

10.34%-98.57M

9.25%-222.03M

2.63%-109.93M

Share of profits of associates

79.26%-197K

94.62%-47K

74.32%-950K

51.34%-874K

-6.32%-3.7M

-9.51%-1.8M

67.63%-3.48M

79.00%-1.64M

32.29%-10.75M

-60.66%-7.81M

Earning before tax

-325.76%-368.23M

-127.70%-82.94M

-86.68%163.11M

-57.64%299.43M

45.76%1.22B

50.46%706.81M

-66.67%840.11M

-60.78%469.77M

13.01%2.52B

20.96%1.2B

Tax

36.87%-89.86M

31.03%-58.82M

-182.98%-142.34M

5.08%-85.29M

243.97%171.54M

-86.30%-89.85M

69.98%-119.14M

74.78%-48.23M

-7.42%-396.86M

-19.40%-191.24M

After-tax profit from continuing operations

-2,305.43%-458.09M

-166.20%-141.76M

-98.51%20.77M

-65.29%214.14M

93.64%1.4B

46.36%616.96M

-66.05%720.97M

-58.13%421.54M

14.12%2.12B

21.26%1.01B

Earning after tax

-2,305.43%-458.09M

-166.20%-141.76M

-98.51%20.77M

-65.29%214.14M

93.64%1.4B

46.36%616.96M

-66.05%720.97M

-58.13%421.54M

14.12%2.12B

21.26%1.01B

Minority profit

-248.45%-116.02M

-1,169.60%-33.84M

-130.03%-33.3M

-91.72%3.16M

354.75%110.87M

380.91%38.22M

-122.84%-43.52M

-89.66%7.95M

-3.46%190.57M

-21.72%76.85M

Profit attributable to shareholders

-732.68%-342.07M

-151.15%-107.92M

-95.79%54.07M

-63.55%210.98M

68.11%1.29B

39.93%578.74M

-60.45%764.49M

-55.52%413.59M

16.21%1.93B

27.02%929.83M

Basic earnings per share

-734.58%-0.0679

-151.07%-0.0214

-95.81%0.0107

-63.53%0.0419

68.12%0.2552

39.95%0.1149

-60.45%0.1518

-55.53%0.0821

16.20%0.3838

26.96%0.1846

Diluted earnings per share

-734.58%-0.0679

-151.07%-0.0214

-95.81%0.0107

-63.53%0.0419

68.12%0.2552

39.95%0.1149

-60.45%0.1518

-55.53%0.0821

16.20%0.3838

26.96%0.1846

Currency Unit

CNY

Accounting Standards

HKAS

Audit Opinions

Unqualified Opinion

Auditor

Hong Kong Lixin Dehao Certified Public Accountants Limited

Ernst & Young

	(FY)Dec 31, 2025	(Q6)Jun 30, 2025	(FY)Dec 31, 2024	(Q6)Jun 30, 2024	(FY)Dec 31, 2023	(Q6)Jun 30, 2023	(FY)Dec 31, 2022	(Q6)Jun 30, 2022	(FY)Dec 31, 2021	(Q6)Jun 30, 2021
Turnover	-10.69%14.74B	-11.00%7.46B	-8.90%16.51B	-9.86%8.39B	26.69%18.12B	57.37%9.3B	-24.92%14.3B	-27.46%5.91B	28.68%19.05B	22.45%8.15B
Operating income	-10.69%14.74B	-11.00%7.46B	-8.90%16.51B	-9.86%8.39B	26.69%18.12B	57.37%9.3B	-24.92%14.3B	-27.46%5.91B	28.68%19.05B	22.45%8.15B
Cost of sales	11.55%-7.65B	11.46%-3.83B	2.19%-8.65B	4.86%-4.32B	-24.51%-8.85B	-53.56%-4.54B	1.63%-7.11B	5.94%-2.96B	-27.17%-7.22B	-19.26%-3.15B
Operating expenses	11.55%-7.65B	11.46%-3.83B	2.19%-8.65B	4.86%-4.32B	-24.51%-8.85B	-53.56%-4.54B	1.63%-7.11B	5.94%-2.96B	-27.17%-7.22B	-19.26%-3.15B
Gross profit	-9.74%7.09B	-10.51%3.63B	-15.29%7.86B	-14.64%4.06B	28.84%9.27B	61.19%4.76B	-39.15%7.2B	-41.00%2.95B	29.62%11.83B	24.54%5B
Selling expenses	8.57%-4.95B	7.13%-2.56B	15.37%-5.42B	13.63%-2.75B	-39.08%-6.4B	-85.61%-3.19B	39.28%-4.6B	43.58%-1.72B	-35.71%-7.58B	-24.58%-3.04B
Administrative expenses	-5.46%-1.12B	2.27%-500.54M	-1.38%-1.06B	-10.20%-512.15M	-10.47%-1.04B	-15.72%-464.75M	3.08%-944.4M	-5.77%-401.61M	-37.77%-974.45M	-13.79%-379.7M
Research and development expenses	14.18%-511.47M	4.40%-256.12M	13.07%-596.01M	14.57%-267.93M	-12.06%-685.63M	1.23%-313.61M	11.90%-611.83M	-7.75%-317.53M	-26.15%-694.44M	-20.13%-294.7M
Impairment and provision	-99.49%-212.57M	-17.07%-185.88M	-1,037.67%-106.55M	-232.37%-158.77M	7.02%-9.37M	-29.33%-47.77M	27.42%-10.07M	20.19%-36.94M	74.17%-13.88M	-39.65%-46.28M
-Other impairment is provision	-99.49%-212.57M	-17.07%-185.88M	-1,037.67%-106.55M	-232.37%-158.77M	7.02%-9.37M	-29.33%-47.77M	27.42%-10.07M	20.19%-36.94M	74.17%-13.88M	-39.65%-46.28M
Special items of operating profit	-65.79%-565.7M	-1,255.45%-171.34M	-215.94%-341.22M	-78.55%14.83M	712.16%294.3M	-24.19%69.13M	-80.79%36.24M	18.56%91.19M	-28.22%188.63M	-47.42%76.91M
Operating profit	-180.13%-268.9M	-109.28%-35.69M	-76.49%335.59M	-52.76%384.58M	34.11%1.43B	42.82%814.05M	-61.34%1.06B	-56.68%569.97M	10.54%2.75B	18.73%1.32B
Financing cost	42.21%-99.13M	43.99%-47.2M	13.82%-171.54M	20.07%-84.27M	9.81%-199.05M	-6.97%-105.44M	0.60%-220.7M	10.34%-98.57M	9.25%-222.03M	2.63%-109.93M
Share of profits of associates	79.26%-197K	94.62%-47K	74.32%-950K	51.34%-874K	-6.32%-3.7M	-9.51%-1.8M	67.63%-3.48M	79.00%-1.64M	32.29%-10.75M	-60.66%-7.81M
Earning before tax	-325.76%-368.23M	-127.70%-82.94M	-86.68%163.11M	-57.64%299.43M	45.76%1.22B	50.46%706.81M	-66.67%840.11M	-60.78%469.77M	13.01%2.52B	20.96%1.2B
Tax	36.87%-89.86M	31.03%-58.82M	-182.98%-142.34M	5.08%-85.29M	243.97%171.54M	-86.30%-89.85M	69.98%-119.14M	74.78%-48.23M	-7.42%-396.86M	-19.40%-191.24M
After-tax profit from continuing operations	-2,305.43%-458.09M	-166.20%-141.76M	-98.51%20.77M	-65.29%214.14M	93.64%1.4B	46.36%616.96M	-66.05%720.97M	-58.13%421.54M	14.12%2.12B	21.26%1.01B
Earning after tax	-2,305.43%-458.09M	-166.20%-141.76M	-98.51%20.77M	-65.29%214.14M	93.64%1.4B	46.36%616.96M	-66.05%720.97M	-58.13%421.54M	14.12%2.12B	21.26%1.01B
Minority profit	-248.45%-116.02M	-1,169.60%-33.84M	-130.03%-33.3M	-91.72%3.16M	354.75%110.87M	380.91%38.22M	-122.84%-43.52M	-89.66%7.95M	-3.46%190.57M	-21.72%76.85M
Profit attributable to shareholders	-732.68%-342.07M	-151.15%-107.92M	-95.79%54.07M	-63.55%210.98M	68.11%1.29B	39.93%578.74M	-60.45%764.49M	-55.52%413.59M	16.21%1.93B	27.02%929.83M
Basic earnings per share	-734.58%-0.0679	-151.07%-0.0214	-95.81%0.0107	-63.53%0.0419	68.12%0.2552	39.95%0.1149	-60.45%0.1518	-55.53%0.0821	16.20%0.3838	26.96%0.1846
Diluted earnings per share	-734.58%-0.0679	-151.07%-0.0214	-95.81%0.0107	-63.53%0.0419	68.12%0.2552	39.95%0.1149	-60.45%0.1518	-55.53%0.0821	16.20%0.3838	26.96%0.1846
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS
Audit Opinions	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--
Auditor	Hong Kong Lixin Dehao Certified Public Accountants Limited	--	Ernst & Young	--	Ernst & Young	--	Ernst & Young	--	Ernst & Young	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More

牛牛課堂

Oct 13, 2025 18:05

[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?

Food流油

Apr 14, 2025 15:43

"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"